Raffles Medical Group Ltd
RAFLFOTCHealthcare● Active
$0.80
$-0.01(-0.63%)
Market Cap$1.5B
P/E Ratio—
52W High$0.83
52W Low$0.6
Raffles Medical Group Ltd (RAFLF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · RAFLF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.76B | $0.75B | $0.71B | $0.82B | $0.72B |
| Cost of Revenue | $0.63B | $0.27B | $0.39B | $0.13B | $0.14B |
| Gross Profit | $0.14B | $0.49B | $0.32B | $0.64B | $0.58B |
| Gross Margin %(computed) | 17.87% | 64.68% | 44.62% | 77.77% | 80.21% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.14B | $0.10B | $0.00B |
| Total Operating Expenses | $0.41B | $0.40B | $0.20B | $0.20B | $0.46B |
| Operating Income | $0.09B | $0.08B | $0.12B | $0.20B | $0.12B |
| Operating Margin %(computed) | 11.66% | 10.98% | 16.35% | 23.80% | 16.76% |
| Interest Income | $0.01B | $0.01B | $0.01B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.01B | $0.01B | $0.01B | $0.01B |
| Income Before Tax | $0.09B | $0.09B | $0.12B | $0.19B | $0.12B |
| Income Tax Expense | $0.02B | $0.02B | $0.03B | $0.05B | $0.03B |
| Net Income | $0.07B | $0.06B | $0.09B | $0.14B | $0.08B |
| Net Margin %(computed) | 9.22% | 8.28% | 12.73% | 17.40% | 11.63% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.04 | $0.03 | $0.05 | $0.08 | $0.05 |
| Wtd Avg Shares | 1.85B | 1.86B | 1.86B | 1.86B | 1.87B |
| EBITDA | $0.14B | $0.14B | $0.13B | $0.24B | $0.16B |
| EBITDA Margin %(computed) | 18.60% | 18.07% | 18.77% | 28.66% | 22.28% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · SGD · B
Explore more Raffles Medical Group Ltd data
About Raffles Medical Group Ltd (RAFLF) Income Statement
Raffles Medical Group Ltd (RAFLF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, RAFLF reported revenue of $0.76B, gross profit of $0.14B (gross margin 17.87%), and net income of $0.07B — a net profit margin of 9.22%.
Frequently asked questions
RAFLF · 4 questionsRaffles Medical Group Ltd (RAFLF) reported revenue of $0.76B for 2025, up 1.8% year-over-year.
RAFLF revenueRAFLF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09